Showing 1 - 9 of 9
Business, Peter Hanbury and Jue Wang, Published on 20/03/2025
» DeepSeek, a Chinese artificial intelligence startup founded in 2023, has quickly made waves in the global industry. With fewer than 200 employees and backed by the quant fund High-Flyer ($8 billion in assets under management), the company released its open-source model, DeepSeek R1, one day before the announcement of OpenAI's $500-billion Stargate project in the United States.
Business, Peter Loftus, Published on 28/02/2022
» Healthcare companies that came up with effective Covid-19 vaccines, treatments and tests are seeing a huge financial payoff and are starting to spend their cash, while grappling with questions about whether the growth is sustainable.
Business, Jonathan D. Rockoff & Peter Loftus, Published on 15/11/2021
» Johnson & Johnson plans to break up into two companies, splitting off the $15-billion-a-year division that sells Band-Aid bandages, Tylenol medicines and Johnson's Baby Powder in a shift indicating just how much healthcare has changed since the company helped pioneer the industry.
Business, Peter Grant, Published on 14/09/2021
» One World Trade Center, the 1,776-foot office building that rose in place of the Twin Towers destroyed on Sept. 11, cost $3.8 billion and is the most expensive skyscraper ever built in the U.S.
Business, Peter Grant, Published on 18/03/2021
» The badly battered lodging business is stirring to life, roused by hotel owners and investors betting that bookings will pick up when Covid-19 vaccines become widespread and more Americans itch to travel again.
Asia focus, Christine Loh, Pamela Mar, Peter Seligmann and Lin Xu in Hong Kong, Published on 22/02/2021
» Optimism is in the air in Asia, where the new Regional Comprehensive Economic Partnership has brightened prospects for a post-pandemic recovery and a revival of multilateralism. Even more promising, there is growing regional agreement on the need to address climate change.
Business, Peter Landers, Published on 22/09/2020
» Kenichiro Yoshida remembers the day--Sept. 17, 2014--that he felt Sony Corp. hit bottom.
Business, Peter Loftus, Published on 26/02/2020
» Drugmakers Johnson & Johnson, Sanofi SA and Inovio Pharmaceuticals Inc. have started to develop coronavirus vaccines, and human studies of them could start in anywhere from a few months to about a year from now. The efforts come as Moderna Inc. has shipped a batch of its experimental coronavirus vaccine to U.S. researchers for human testing.
Business, Peter Loftus & Betsy McKay, Published on 25/01/2020
» Several drugmakers are racing to develop vaccines that could protect against the new respiratory virus originating in China, as fears mount it could spread more widely.